Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

12.70
Delayed Data
As of Mar 27
 -0.08 / -0.63%
Today’s Change
10.85
Today|||52-Week Range
18.48
-10.25%
Year-to-Date
No recent news for Keryx Biopharmaceuticals Inc.

Today’s Trading

Previous close12.78
Today’s open12.71
Day’s range-- - --
Volume1,333,162
Average volume (3 months)1,736,221
Market cap$1.3B
Dividend yield--
Data as of 03/27/2015

Growth & Valuation

Earnings growth (last year)-112.07%
Earnings growth (this year)+25.54%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+54.64%
P/E ratioNM
Price/Sales118.95
Price/Book16.02

Competitors

 Today’s
change
Today’s
% change
NKTRNektar Therapeutics+0.18+1.65%
SGMOSangamo BioSciences ...+0.63+4.23%
NXTMNxStage Medical Inc+0.19+1.13%
ARIAARIAD Pharmaceutical...+0.22+2.69%
Data as of 03/27/2015

Financials

Next reporting dateMay 12, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$10.8M
Annual profit (last year)-$111.5M
Net profit margin-1,030.19%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ronald Bentsur
President, Chief Operating Officer &
Director
Gregory P. Madison
Corporate headquarters
New York, New York

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account